Awards

Congratulations to the IPOS 2018 Award Winners!

2018 Arthur M. Sutherland Award and Memorial Lecture Recipient

Professor Richard Fielding, BA (Hons), Dip Clin Psych, PhD (Hong Kong)

Richard Fielding graduated in Psychology & Zoology from the University of London in 1974, completed his clinical psychology training in Manchester establishing one of the first cardiac rehabilitation programmes and support groups for women with breast cancer in the UK. After finishing a PhD from the University of Sheffield in medical psychology, he moved east, joining HKU as Assistant Professor in Medical Psychology in 1982. His research interests include social aspects of cancer and optimization of care for patients with chronic illness. He retired from full-time academia in 2017 but remains Honourary Professor of Medical Psychology in Public Health. He was formerly Head of the Behavioural Sciences Unit, and Director of CePORT, the Centre for Psycho-Oncology Research & Training, and of the Health Behaviour Research Group in the School of Public Health at HKU. Professor Fielding is on the Editorial Boards of the journals Psycho-Oncology, Health Psychology and Public Health, amongst others and has authored over 220 peer-reviewed papers, books and chapters. He is a recipient of the BMA Medical Book of the Year Award for his text on Clinical Communication Skills and has served in various board and committee positions of the International Psycho-Oncology Society, and is a founder member of the Asia-Pacific Psycho-Oncology Network. He is currently co-Chair of the Scientific Committee of the 2018 World Congress of Psycho-Oncology.

2018 Bernard Fox Memorial Award Recipient

Professor Brian Kelly, BMed (Newcastle), PhD, FRANZCP, FAChPM (Australia)

Professor Brian Kelly is Dean of Medicine – Joint Medical Program, Head of the School of Medicine and Public Health and Professor of Psychiatry at the University of Newcastle, Australia. He has a longstanding background in clinical research addressing the psychosocial aspects of cancer and palliative care. Prof Kelly has undertaken large scale longitudinal cohort and intervention studies across mental health, palliative and end-of-life care, and psycho-oncology including research to explore ways to improve identification of psychosocial needs, health service models in psycho-oncology and integration of psychosocial care into cancer services. He has a broad interest in the strategies to improve education and support of health professionals in oncology and palliative care, including methods of clinical supervision and support, education in communication skills, and addressing the impact of care on clinicians. He has conducted research focussed on the patterns of psychiatric symptoms and disorder experienced by people with cancer, the doctor-patient relationship in end-of-life care in cancer, and longitudinal studies of bereavement in the cancer context, focussing on family and caregiver outcomes. His experience also extends to research and clinical service development addressing health care needs and services in rural and remote regions, and the psychosocial needs of Indigenous people with cancer. He extensive experience as a clinician in the field of Consultation-Liaison Psychiatry with a focus on oncology and palliative care. Prof Kelly has contributed to national and international leadership roles including the Australian Psycho-oncology Co-operative Research Group and Chair of the IPOS Governance Committee. As Adjunct Professor in the Department of Oncology, with the Cummings School of Medicine, University of Calgary and Tom Baker Cancer Centre, he has also played a leadership role in the promotion of a unique cross-national collaboration in Psycho-oncology research.

2018 Noemi Fisman Award for Lifetime Clinical Excellence Recipient

Dr. Lili Tang, MD (China)

Dr. Lili Tang is the Director of the Department of Psycho-Oncology in Peking University Cancer Hospital. She is also the first psychiatrist involving in palliative care and psycho-oncology in Mainland China. In 2005, Dr. Tang went to Memorial Sloan Kettering Cancer Center and Tom Baker Cancer center as a visiting scholar. In these two famous Cancer Center, Dr. Tang gained lots of experience and guidance. She provides symptom management and psychotherapy for both outpatients and inpatients. During over last two decades, she and her team have served more than 20000 cancer patients. She edited the first textbook of Psycho-oncology in 2012 and set up curriculum on psycho-oncology for postgraduate students majoring in Clinical oncology in Peking University in 2015. She has been the president of Chinese Psycho-Oncology Society (CPOS) and Beijing Psycho-Oncology Society (BPOS) since 2013. With her effort, CPOS has been developing rapidly and become an academic organization with more than 2000 members. Under her leadership, CPOS helped twenty caner hospitals set up psychosocial services, distributed in 18/34 provinces in China. In 2016, under her advocacy and organization, CPOS published the first Chinese Psychosocial Oncology Therapy Guidelines for Cancer patient in China, which represented a milestone in the development of Chinese psycho-oncology clinical practice. Supported by the funding from Chinese government, Dr. Lili Tang has built international collaboration in Asian, America, Canada and Australia to hold trainings on psycho-oncology, palliative care and doctor-patient communication all over the country and to conduct researches in these fields and her department has been evaluated as the model Unit of Chinese standardized training of psychosocial service and doctor-patient communication in cancer patients (2015.12-2020.12).

2018 Hiroomi Kawano New Investigator Award Recipient

Dr. Fiona Schulte, PhD (Canada)

Fiona Schulte is an Assistant Professor in the Department of Oncology, Division of Psychosocial Oncology in the Cumming School of Medicine at the University of Calgary. She is also a registered psychologist in the Hematology, Oncology and Transplant Program at the Alberta Children’s Hospital. Fiona is Vice-President of the Canadian Association of Psychosocial Oncology and a member of a number of national and international committees focused on improving the care of pediatric and adolescent cancer patients, survivors and their families. Fiona’s research is broadly interested in enhancing the patient and family experience for patients diagnosed with cancer and improving the psychosocial late effects of childhood cancer survivors. She has been recognized for her research by receiving an International Society of Pediatric Oncology Young Investigator Award and Calgary’s Avenue Magazine Top 40 Under 40.


Awards Criteria

  • An award recipient may receive only one Society award in any calendar year.
  • No recipient of an IPOS Award shall be eligible for nomination to a second or subsequent award within a period of 10 years from the date of their previous award.
  • Each award shall have a peer review panel consisting of at least: (a) one previous recipient of the award, (b) one member of the Federation, and (c) one member of the Awards Committee.
  • The Society Treasurer shall review, ratify where required and advise on all financial recommendations and requests made by the Awards Committee.
  • For all awards, consideration may be given for travel reimbursement and/or registration fee waiver, if required.
  • All award nominations must include a completed and signed nomination form, a letter of nomination from the nominator, two letters of support for the nomination from other individuals to whom the nominee is known, the curriculum vitae or resume of the nominee, and any additional paperwork required by the specific award for which the individual is being nominated.
  • Award recipients must be available to attend the IPOS World Congress at which the award is to be presented.
  • Specific criteria for each award are identified below.

Jimmie Holland Memorial Award
Arthur M. Sutherland Award and Memorial Lecture
Bernard Fox Memorial Award
Noemi Fisman Award for Lifetime Clinical Excellence
Hiroomi Kawano New Investigator Award
Society Distinguished Life Fellowship Award
President’s Community Award for Distinguished Contributions to IPOS

Jimmie Holland Memorial Award

The Jimmie Holland Memorial Award honors an IPOS or psycho-oncology community member recognized for making a unique contribution considered to be a highly creative or pioneering innovation or activity that advances the field of Psycho-oncology. The award is unique in its recognition as Jimmie Holland as a pioneer and chief innovator of our time, as well as recognizes her enormous contribution as mentor.

This award is considered for nominees within early to senior levels of careers with documentation and support to provide clear evidence of what is “visionary or outside the box” about the activity and how it represents an outstanding idea or activity or line of work, within the chosen area of the field of psycho-oncology.

It is important that the nominator provide evidence in his/her letter of recommendation that the nominee meets the criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known which, provides evidence that the nominee meets these criteria. The nominee should not have received any other IPOS award previously.

The award will be launched and presented during the President´s Plenary session recognizing Jimmie Holland at the IPOS Congress in Hong Kong. The award recipient will be invited to make a few brief remarks related to their specific enterprise or vision.

  • IPOS nomination form, signed by nominee
  • Letter of nomination from the nominator, specifying why the nominee meets the award description above
  • Two letters of support from other individuals to whom the nominee is known, also specifying why the nominee meets the award description above.

Arthur M. Sutherland Award and Memorial Lecture

The Arthur M. Sutherland Award honors an IPOS or psycho-oncology community member with a lifetime achievement in the field of psycho-oncology. This is a late career award and recognizes sustained and distinguished output in psycho-oncology over their whole career. This is the Society’s most important award and reflects the international standing of the recipient.

The recipient will have achieved international recognition for his/her work and be considered to have contributed important innovations to the field of psycho-oncology. Quantity of output is less important than evidence of international standing and innovation across an individual’s whole career. It is important that the nominator provides evidence in their letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria.

This award will be presented at the next IPOS World Congress of Psycho-Oncology. The award recipient will be invited to present an overview on a topic related to their research as part of a plenary session of the IPOS World Congress. Additionally, the Sutherland Award recipient may be invited to publish an article in the official journal of IPOS, Psycho-Oncology, at the discretion of the journal’s Editorial Board.

  • IPOS Award Nomination Form, signed by the nominee
  • Nominee’s curriculum vitae or resume
  • Letter of nomination from the nominator, specifying why the nominee meets the award description above
  • Two letters of support from other individuals to whom the nominee is known, also specifying why the nominee meets the award description above

[top of page]

Bernard Fox Memorial Award

The Bernard Fox Memorial Award honors an IPOS or psycho-oncology community member who has made an outstanding contribution in education or research to the field of psycho-oncology. The primary focus is on the academic and educational output of the nominee.

This is a mid to late career award, and the nominee may work as an educator, as a researcher and/or provide clear evidence of being a leader in his/her chosen area of psycho-oncology. It is important that the nominator provides evidence in his/her letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria.

This award will be presented at the next IPOS World Congress of Psycho-Oncology. The award recipient will be invited to present an overview on a topic related to their research as part of a plenary session of the IPOS World Congress.

  • IPOS Award Nomination Form, signed by the nominee
  • Nominee’s curriculum vitae or resume
  • Letter of nomination from the nominator, specifying why the nominee meets the award description above
  • Two letters of support from other individuals to whom the nominee is known, also specifying why the nominee meets the award description above

[top of page]

Noemi Fisman Award for Lifetime Clinical Excellence

The Noemi Fisman Award for Lifetime Clinical Excellence honors an IPOS or psycho-oncology community member in recognition of outstanding clinical contributions to the field of psycho-oncology. He/she must have served for a major proportion of his/her career as a clinician and be able to demonstrate novel, beneficial and substantial initiatives impacting directly on the care of patients and his/her families either through their own practice or practice developments.

Candidates must be licensed and have been actively practicing in the field of clinical psycho-oncology for a minimum of 20 years. The award focuses on the distinctive contribution made in developing services to patients and families. Innovation and sustained successful clinical service of outstanding character should be what distinguishes the recipient of this award. It is important that the nominator provide evidence in his/her letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria.

This award will be presented at the IPOS World Congress of Psycho-Oncology. The award recipient may be asked to provide a brief overview of his/her work (5 minutes) at the IPOS World Congress.

  • IPOS Award Nomination Form, signed by the nominee
  • Nominee’s curriculum vitae or resume
  • Letter of nomination from the nominator, specifying why the nominee meets the award description above
  • Two letters of support from other individuals to whom the nominee is known, also specifying why the nominee meets the award description above

[top of page]

Hiroomi Kawano New Investigator Award

The Hiroomi Kawano New Investigator Award honors a new investigator for outstanding research contributions in the field of psycho-oncology and is an early career award. Candidates must be within seven years of active work in psycho-oncology after completing his/her postgraduate, fellowship or equivalent specialist training (defined as a PhD or MD or equivalent). This award is sponsored by the Hiroomi Kawano Foundation in Japan.

The award is linked to professional attainment rather than to age. Recipients are distinguished by the level and quality of research output at this early career stage. It is important that the nominator provides evidence in his/her letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria.

This award will be presented at the IPOS World Congress of Psycho-Oncology. The award recipient may be asked to provide a brief overview of his/her work (5 minutes) at the IPOS World Congress.

  • IPOS Award Nomination Form, signed by the nominee
  • Nominee’s curriculum vitae or resume, with details of specific termination dates of degrees and post-graduate training
  • Letter of nomination from the nominator, who must be an Active Member of IPOS or a full member of any national psycho-oncology society, specifying why the nominee meets the award description above
  • Two letters of support from other individuals to whom the nominee is known, also specifying why the nominee meets the award description above
  • A statement from the nominee, not to exceed 500 words, that highlights significant research accomplishments in the area of psycho-oncology
  • Copies of up to four publications that represent the candidate’s research work

[top of page]

Society Distinguished Life Fellowship Award

The Society Distinguished Life Fellowship Award recognizes extraordinary and notable contributions to the organization and success of IPOS. This award is only for one who has made a singular contribution to the Society and its work. The Distinguished Life Fellowship Award is limited to past or present IPOS members.

The award shall carry with it Honorary Life Membership in IPOS, with a special plaque for the fellow. The award shall also include waived IPOS membership dues and the possibility of waived World Congress registration fees at the Congress at which the award is presented. Nominees should be, or have been, members of IPOS for at least 10 years and are not eligible if not a member within the past five years.

Nominations for this award can only be made by the IPOS Board of Directors.

The IPOS Awards Committee shall select recipients of IPOS awards. If no suitable nominations are received, no awards will be given.

[top of page]

President’s Community Award for Distinguished Contributions to IPOS

The President’s Community Award for Distinguished Contributions to IPOS is a discretionary award that is made to an individual, group or organization in the community that, in the opinion of the Board has made an outstanding contribution of great significant to the Society.

  1. Nominations are made by a member of the IPOS Board and all nominations must be seconded by two members of the Board and approved by a two-thirds of the Board.
  2. Given the special nature of this award, it is envisaged that it will be awarded only occasionally.
  3. The awardee shall receive a plaque and citation from the Board and s/he (or a representative, if an organization is the recipient) shall be invited to receive these at the World Congress. Congress fees maybe be waived on this occasion.

[top of page]

View the list of previous IPOS Award winners